In addition, Medel et al. also demonstrated that dendritic cells could enhance CD8+ T-cell–specific responses through activation of the IRE1α/XBP1 axis to exert an anti-tumor effect (Medel et al., 2018). The gene discussed is CD8A; the disease is neoplasm.